Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action
Open Access
- 4 March 2024
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 173, 116373
Abstract
No abstract availableKeywords
This publication has 192 references indexed in Scilit:
- In‐silico identification of Tyr232 in AMPKα2 as a dephosphorylation site for the protein tyrosine phosphatase PTP‐PESTProteins: Structure, Function, and Bioinformatics, 2023
- The role of mitochondrial dysfunction in Alzheimer's disease pathogenesisAlzheimer's & Dementia, 2022
- Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factorsJournal of Neural Transmission, 2021
- Mechanisms of AMPK in the maintenance of ATP balance during energy metabolismCell Biology International, 2018
- Inhibition of Akt Phosphorylation Diminishes Mitochondrial Biogenesis Regulators, Tricarboxylic Acid Cycle Activity and Exacerbates Recognition Memory Deficit in Rat Model of Alzheimer’s DiseaseCellular and Molecular Neurobiology, 2014
- The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein—a well-known, yet poorly understood drug transporterInvestigational New Drugs, 2014
- The role of APP proteolytic processing in lipid metabolismExperimental Brain Research, 2011
- AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathiesActa Neuropathologica, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of DementiaArchives of Neurology, 2009